Litcius/Paper detail

Low-density lipoprotein (LDL) levels and risk of arterial occlusive events in chronic myeloid leukemia patients treated with nilotinib

Giovanni Caocci, Olga Mulas, Isabella Capodanno, Massimiliano Bonifacio, Mario Annunziata, Sara Galimberti, Luigiana Luciano, Mario Tiribelli, Bruno Martino, Fausto Castagnetti, Gianni Binotto, Patrizia Pregno, Fabio Stagno, Elisabetta Abruzzese, Monica Bocchia, Antonella Gozzini, Francesco Albano, Claudio Fozza, Debora Luzi, Fabio Efficace, Maria Pina Simula, Luigi Scaffidi, Claudia Baratè, F. De Gregorio, Rossella Stella, Gabriele Gugliotta, Francesca Pirillo, Malgorzata Monika Trawinska, Anna Sicuranza, Daniele Cattaneo, Immacolata Attolico, Emilia Scalzulli, Alessandra Iurlo, Robin Foà, Massimo Breccia, Giorgio La Nasa

2021Annals of Hematology17 citationsDOIOpen Access PDF

Topics & Concepts

NilotinibMedicineInternal medicineDyslipidemiaGastroenterologyIncidence (geometry)CholesterolMyeloid leukemiaCumulative incidenceCardiologyCohortImatinibOpticsObesityPhysicsChronic Myeloid Leukemia TreatmentsLipoproteins and Cardiovascular HealthChemotherapy-induced cardiotoxicity and mitigation